7.3 COORDINACIÓN INTERINSTITUCIONAL

1. Coulam CB. Epidemiology of recurrent spontaneous abortion. Am J Reprod Immunol. 1991;26(1):23- 27.

2. Branch DW, Gibson M, Silver RM. Clinical practice. Recurrent miscarriage. N Engl J Med. 2010;363(18): 1740-1747.

3. Larsen EC, Christiansen OB, Kolte AM, Macklon N. New insights into mechanisms behind miscarriage.

BMC Med. 2013;11:154.

4. Yang CJ, Stone P, Stewart AW. The epidemiology of recurrent miscarriage: a descriptive study of 1214 prepregnant women with recurrent miscarriage. Aust N Z J Obstet Gynaecol. 2006;46(4):316-322. 5. Porter TF, Scott JR. Evidence-based care of recurrent miscarriage. Best Pract Res Clin Obstet Gynaecol.

2005;19(1):85-101.

6. Meuleman T, Lashley LE, Dekkers OM, van Lith JM, Claas FH, Bloemenkamp KW. HLA associations and HLA sharing in recurrent miscarriage: A systematic review and meta-analysis. Hum Immunol. 2015;76(5):362-373.

7. Apps R, Gardner L, Moffett A. A critical look at HLA-G. Trends Immunol. 2008;29(7):313-321. 8. Castelli EC, Mendes-Junior CT, Deghaide NH, et al. The genetic structure of 3’untranslated region

of the HLA-G gene: polymorphisms and haplotypes. Genes Immun. 2010;11(2):134-141.

9. Castelli EC, Mendes-Junior CT, Veiga-Castelli LC, Roger M, Moreau P, Donadi EA. A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution.

Mol Biol Evol. 2011;28(11):3069-3086.

10. Hviid TV, Hylenius S, Rorbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics. 2003;55(2):63-79. 11. Chen XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX. The 14 bp deletion polymorphisms in

HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens. 2008;72(4):335-341.

12. Hviid TV, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics. 2004;56(3):135-141. 13. Martelli-Palomino G, Pancotto JA, Muniz YC, et al. Polymorphic sites at the 3’ untranslated region

of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population. PLoS One. 2013;8(10):e71742.

14. Hunt JS, Jadhav L, Chu W, Geraghty DE, Ober C. Soluble HLA-G circulates in maternal blood during pregnancy. Am J Obstet Gynecol. 2000;183(3):682-688.

15. Carosella ED, Rouas-Freiss N, Roux DT, Moreau P, LeMaoult J. HLA-G: An Immune Checkpoint Molecule. Adv Immunol. 2015;127:33-144.

16. Kapasi K, Albert SE, Yie S, Zavazava N, Librach CL. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology. 2000;101(2):191-200.

17. Athanassakis I, Paflis M, Ranella A, Vassiliadis S. Detection of soluble HLA-G levels in maternal serum can be predictive for a successful pregnancy. Transplant Proc. 1999;31(4):1834-1837.

18. Zidi I, Rizzo R, Bouaziz A, et al. sHLA-G1 and HLA-G5 levels are decreased in Tunisian women with multiple abortion. Hum Immunol. 2016;77(4):342-345.

19. Pfeiffer KA, Rebmann V, Passler M, et al. Soluble HLA levels in early pregnancy after in vitro fertilization.

Hum Immunol. 2000;61(6):559-564.

20. Fan W, Li S, Huang Z, Chen Q. Relationship between HLA-G polymorphism and susceptibility to recurrent miscarriage: A meta-analysis of non-family-based studies. J Assist Reprod Genet. 2014; 31(2):173-184.

21. Wang X, Jiang W, Zhang D. Association of 14-bp insertion/deletion polymorphism of HLA-G gene with unexplained recurrent spontaneous abortion: a meta-analysis. Tissue Antigens. 2013;81(2):108- 115.

22. Visser J, Ulander VM, Helmerhorst FM, et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial. Thromb Haemost. 2011;105(2):295-301.

23. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295- 306.

3

24. Coomarasamy A, Williams H, Truchanowicz E, et al. PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation. Health Technol Assess. 2016;20(41):1-92.

25. McNamee K, Dawood F, Farquharson R. Recurrent miscarriage and thrombophilia: an update. Curr Opin Obstet Gynecol. 2012;24(4):229-234.

26. Brown M, Lindheimer M, de Swiet M, Van Assche A, Moutquin J. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). In Hypertens Pregnancy 2001:IX-XIV.

27. Kloosterman GJ. Intrauterine growth and intrauterine growth curves. Maandschr Kindergeneeskd. 1969;37(7):209-225.

28. Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens. 2002;60(2):122-132.

29. Whole-genome sequence variation, population structure and demographic history of the Dutch population. Nat Genet. 2014;46(8):818-825.

30. Hardy GH. Mendelian proportions in a mixed population. Science. 1908;28(706):49-50.

31. Weinberg W. On the demonstration of herdity in man. Translated and reprinted in S.H. Boyer (Ed.).

Papers on human genetics. 1963:4-15.

32. Jirous J, Diejomaoh M, Al-Othman S, Al-Abdulhadi F, Al-Marzouk N, Sugathan T. A correlation of the uterine and ovarian blood flows with parity of nonpregnant women having a history of recurrent spontaneous abortions. Gynecol Obstet Invest. 2001;52(1):51-54.

33. Michita RT, Zambra FM, Fraga LR, et al. A tug-of-war between tolerance and rejection - New evidence for 3’UTR HLA-G haplotypes influence in recurrent pregnancy loss. Hum Immunol. 2016;77(10):892- 897.

34. Klitkou L, Dahl M, Hviid TV, et al. Human leukocyte antigen (HLA)-G during pregnancy part I: correlations between maternal soluble HLA-G at midterm, at term, and umbilical cord blood soluble HLA-G at term. Hum Immunol. 2015;76(4):254-259.

35. Yie SM, Li LH, Xiao R, Librach CL. A single base-pair mutation in the 3’-untranslated region of HLA-G mRNA is associated with pre-eclampsia. Mol Hum Reprod. 2008;14(11):649-653.

36. Veit TD, Chies JA. Tolerance versus immune response -- microRNAs as important elements in the regulation of the HLA-G gene expression. Transpl Immunol. 2009;20(4):229-231.

37. Le Bouteiller P. HLA-G in human early pregnancy: control of uterine immune cell activation and likely vascular remodeling. Biomed J. 2015;38(1):32-38.

38. Abbas A, Javed S, Agrawal S. Transcriptional status of HLA-G at the maternal-fetal interface in recurrent spontaneous abortion. Int J Gynaecol Obstet. 2006;93(2):148-149.

39. Patel RN, Quack KC, Hill JA, Schust DJ. Expression of membrane-bound HLA-G at the maternal-fetal interface is not associated with pregnancy maintenance among patients with idiopathic recurrent pregnancy loss. Mol Hum Reprod. 2003;9(9):551-557.

40. Emmer PM, Steegers EA, Kerstens HM, et al. Altered phenotype of HLA-G expressing trophoblast and decidual natural killer cells in pathological pregnancies. Hum Reprod. 2002;17(4):1072-1080. 41. Rebmann V, van d, V, Passler M, Pfeiffer K, Krebs D, Grosse-Wilde H. Association of soluble HLA-G

plasma levels with HLA-G alleles. Tissue Antigens. 2001;57(1):15-21.

42. Di CJ, Reynaud-Gaubert M, Carlini F, et al. HLA-G*01:04 approximately UTR3 Recipient Correlates With Lower Survival and Higher Frequency of Chronic Rejection After Lung Transplantation. Am J Transplant. 2015;15(9):2413-2420.

43. Castelli EC, Ramalho J, Porto IO, et al. Insights into HLA-G Genetics Provided by Worldwide Haplotype Diversity. Front Immunol. 2014;5:476.

44. Amiot L, Ferrone S, Grosse-Wilde H, Seliger B. Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention? Cell Mol Life Sci. 2011;68(3):417-431.

45. Zambra N, Gimeno D, Blache D, van LE. Temperament and its heritability in Corriedale and Merino lambs. Animal. 2015;9(3):373-379.

46. Garziera M, Catamo E, Crovella S, et al. Association of the HLA-G 3’UTR polymorphisms with colorectal cancer in Italy: a first insight. Int J Immunogenet. 2016;43(1):32-39.

47. Ober C, Aldrich CL, Chervoneva I, et al. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet. 2003;72(6):1425-1435.

3